Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Covington
Cantor Fitzgerald
McKinsey
US Army
Baxter
Deloitte
Medtronic

Generated: October 21, 2018

DrugPatentWatch Database Preview

COZAAR Drug Profile

« Back to Dashboard

When do Cozaar patents expire, and what generic alternatives are available?

Cozaar is a drug marketed by Merck Sharp Dohme and is included in one NDA.

The generic ingredient in COZAAR is losartan potassium. There are thirty-eight drug master file entries for this compound. Sixty-six suppliers are listed for this compound. Additional details are available on the losartan potassium profile page.

Drug patent expirations by year for COZAAR
Pharmacology for COZAAR
Medical Subject Heading (MeSH) Categories for COZAAR
Synonyms for COZAAR
(1-((2-(1H-TETRAZOL-5-YL)BIPHENYL-4-YL)METHYL)-2-BUTYL-4-CHLORO-1H-IMIDAZOL-5-YL)METHANOL
(1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-4-chloro-1H-imidazol-5-yl)methanol
(1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-4-chloro-1H-imidazol-5-yl)methanol
(1-((2'-(2h-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-butyl-4-chloro-1h-imidazol-5-yl)methanol
(2-BUTYL-4-CHLORO-1-[[2'-(2H-TETRAZOL-5-YL)-4-BIPHENYLYL]METHYL]-1H-IMIDAZOL-5-YL)METHANOL
(2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazol-5-yl)methanol
(2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol
(2-butyl-4-chloro-1-{[2'-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol
[2-butyl-4-chloro-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazol-5-yl]methanol
[2-butyl-5-chloranyl-3-[[4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol
[2-butyl-5-chloro-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol
[2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-4-imidazolyl]methanol
[2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol
[3H]-losartan
[3H]losartan
{2-Butyl-5-chloro-3-[2'-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-imidazol-4-yl}-methanol
114798-26-4
114798-26-4 (Parent)
124750-99-8
124750-99-8 (mono-potassium salt)
1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-((2-(1H-tetrazol-5-yl)(1,1-biphenyl)-4-yl)methyl)-, monopotassium salt
1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-((2'-(1H-tetrazol-5-yl)(1,1'- biphenyl)-4-yl)methyl)-
1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-((2'-(1H-tetrazol-5-yl)(1,1'-bi phenyl)-4-yl)methyl)-, monopotassium salt
1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, monopotassium salt
1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (9CI)
1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-(9CI)
1H-imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-
1H-imidazole-5-methanol,2-butyl-4-chloro-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, monopotassium salt
2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol
2-Butyl-4-chloro-1-(2'-(tetrazol-5-yl)biphenyl-4-ylmethyl)-1H-imidazole-5-methanol potassium
2-Butyl-4-chloro-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)imidazole-5-methanol, monopotassium salt
2-butyl-4-chloro-1-[ p -( o -1 H -tetrazol-5-ylphenyl)benzyl]imidazole-5-methanol monopotassium salt
2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl]imidazole-5-methanol Potassium Salt
2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl]imidazole-5-methanol potassium salt|
2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl-1H-imidazole-5-methanol
2-BUTYL-4-CHLORO-1-[[2'-(1H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL]METHYL]-1H-IMIDAZOLE-5-METHANOL
2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol mono potassium salt
2-butyl-4-chloro-1-[[2'-(1h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1h-imidazole-5-methanol monop
2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol monopotassium salt
2-butyl-4-chloro-1-[[2'-(1h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1h-imidazole-5-methanol, mono
2-butyl-4-chloro-1-[[2'-(2h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1h-imidazole-5-methanol
2-butyl-4-chloro-1-[p-(o-1H-tetrazol-5ylphenyl)benzyl]imidazole-5-methanol
2-Butyl-4-chloro-1-{[2 inverted exclamation marka-(1H-tetrazol-5-yl)(1,1 inverted exclamation marka-biphenyl)-4-yl]methyl}-1H-imidazole-5-methanol monopotassium salt
2-butyl-4-chloro-5-(hydroxymethyl)-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]imidazole
2-Butyl-4-chloro-5-[(potassiooxy)methyl]-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazole
2-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)-biphenyl-4-yl)methyl]imidazole
2-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole
2-n-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole
2-n-butyl-4-chloro-5-hydroxymethyl-1-[[2'-(1H-tetrazol-5-yl)-biphenyl-4-yl]methyl]imidazole
3ST302B24A
54244-EP2269989A1
54244-EP2270011A1
54244-EP2272841A1
54244-EP2277879A1
54244-EP2287165A2
54244-EP2287166A2
54244-EP2292620A2
54244-EP2295053A1
54244-EP2295406A1
54244-EP2298772A1
54244-EP2298776A1
54244-EP2298779A1
54244-EP2301923A1
54244-EP2301931A1
54244-EP2301936A1
54244-EP2305219A1
54244-EP2308562A2
54244-EP2308839A1
750L998
798L264
A803239
AB0013723
AB0013939
AB0072997
AB01275507-01
AB01563296_01
AB07507
AB2000067
AC1L1H3Q
ACT02618
AK162987
AK326126
AKOS015894865
AKOS015917390
AKOS015955543
AKOS015994740
AKOS024462596
AKOS025310168
AKOS025395548
allisartan
Ambap124750-99-8
AN-15300
AN-15301
ANW-42060
API0003216
API0007066
BCP9000861
BCP9000862
BCPP000183
BDBM82258
BG0556
BG0563
BIDD:GT0286
Bio-0060
BRD-K76205745-001-02-5
BSPBio_002695
C07072
C22H22CIKN6OK
C22H22ClN6O.K
C22H23ClN6O
CAS_114798-26-4
CAS-114798-26-4
CCG-100869
CCG-39095
CHEBI:6541
CL23623
Covance
Cozaar (TN)
CPD000469593
CS-2116
CTK8B3241
CTK8E7663
D00357
D03AQG
D08146
D0DD0K
DB00678
DR002602
DR002858
DSSTox_CID_3227
DSSTox_GSID_23227
DSSTox_RID_76933
DTXSID3044209
DTXSID7023227
Du Pont 753
DuP 753
DUP 89
DuP-753
DuP-753 potassium
E-3340
EC 601-329-8
Epitope ID:140137
Ex-89
F2173-0506
FDKIDFYIEWFERB-UHFFFAOYSA-N
FT-0627982
FT-0631074
GP6564
GTPL3941
GTPL590
HE115997
HE298246
HMS1922J13
HMS2051M12
HMS2090O22
HMS2093E22
HMS2235F20
HMS3369F08
HMS3393M12
HSDB 7043
HY-17512
Hyzaar
I06-0124
I06-124
I14-9710
I497
I934
J10063
JMS50MPO89
Jsp001094
Jsp001627
KBio2_002193
KBio2_004761
KBio2_007329
KBio3_001915
KBioGR_001611
KBioSS_002193
KS-00000GI2
KS-00000IQA
KS-5004
L-158086
L000351
L0232
Lifezar
Lortaan
Lorzaan
Lorzaar
Losacar
Losacor
Losaprex
losartan
Losartan (INN)
Losartan [INN:BAN]
losartan monopotassium
Losartan monopotassium salt
LOSARTAN POTASSIUM
Losartan Potassium (DuP 753)
Losartan potassium (JP17/USAN)
Losartan potassium [USAN:USP]
Losartan potassium [USAN]
losartan potassium salt
Losartan potassium, analytical standard
Losartan potassium, European Pharmacopoeia (EP) Reference Standard
Losartan Potassium, pharmaceutical secondary standard; traceable to USP, PhEur, BP
Losartan potassium, United States Pharmacopeia (USP) Reference Standard
losartan, potassium salt
losartanpotassium
Losartic
Losartic (TN)
Lotim
LS-78746
LS-78747
MCULE-5204931675
MFCD00865831
MFCD09850721
MK 0954
MK 954
MK-0954
MK-954
MK0954
MK954
MLS001401407
MolPort-003-666-553
MolPort-003-848-417
MolPort-006-069-365
MolPort-006-167-607
MolPort-006-709-406
MolPort-006-822-644
MolPort-035-395-739
NC00119
NCGC00095125-01
NCGC00095125-02
NCGC00095125-03
NCGC00095125-05
Neo Lotan
Niten
NSC_3961
NSC-758699
NSC758699
Nu-Lotan
Ocsaar
Oprea1_644635
OSCAAR
Pharmakon1600-01504268
Potassium (1-((2-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-4-chloro-1H-imidazol-5-yl)methanolate
potassium (1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-4-chloro-1H-imidazol-5-yl)methanolate
potassium [2-butyl-5-chloro-3-[[4-[2-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol
potassium 5-(4'-((2-butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl)methyl)-[1,1'-biphenyl]-2-yl)tetrazol-1-ide
potassium 5-(4'-((2-butyl-4-chloro-5-(hydroxymethyl)-1h-imidazol-1-yl)methyl)biphenyl-2-yl)tetrazol-
potassium losartan
potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol
PSIFNNKUMBGKDQ-UHFFFAOYSA-N
PubChem9176
Q-201321
Q-201322
RT-013597
RTR-003798
s1359
SAM001246635
SBI-0206766.P001
SC-15834
SC-47229
SCHEMBL42079
SCHEMBL42080
SCHEMBL60
SMR000469593
SPBio_001893
Spectrum_001713
SPECTRUM1504268
Spectrum2_001677
Spectrum3_000998
Spectrum4_001126
Spectrum5_001466
ST24047507
ST51052691
STL419984
Tenopres
Tox21_111435
Tox21_111435_1
TR-003798
UNII-3ST302B24A
UNII-JMS50MPO89
ZINC3873160

US Patents and Regulatory Information for COZAAR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck Sharp Dohme COZAAR losartan potassium TABLET;ORAL 020386-001 Apr 14, 1995 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Merck Sharp Dohme COZAAR losartan potassium TABLET;ORAL 020386-002 Apr 14, 1995 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Merck Sharp Dohme COZAAR losartan potassium TABLET;ORAL 020386-003 Oct 13, 1998 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for COZAAR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck Sharp Dohme COZAAR losartan potassium TABLET;ORAL 020386-001 Apr 14, 1995 ➤ Sign Up ➤ Sign Up
Merck Sharp Dohme COZAAR losartan potassium TABLET;ORAL 020386-003 Oct 13, 1998 ➤ Sign Up ➤ Sign Up
Merck Sharp Dohme COZAAR losartan potassium TABLET;ORAL 020386-003 Oct 13, 1998 ➤ Sign Up ➤ Sign Up
Merck Sharp Dohme COZAAR losartan potassium TABLET;ORAL 020386-001 Apr 14, 1995 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Covington
Cantor Fitzgerald
McKinsey
US Army
Baxter
Deloitte
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.